Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001140361-17-036981)

Filing Details

Accession Number:: 0001140361-17-036981
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2017-09-29 16:52:56
Reporting Period:: 2017-09-27

Accepted Time:: 2017-09-29 16:52:56
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1367644	Emergent Biosolutions Inc.	EBS	Pharmaceutical Preparations (2834)	141902018

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1514588	Adam Havey	400 Professional Dr, Suite 400 Gaithersburg MD 20879	Evp, Business Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2017-09-27	7,885	$22.03	33,931	No	4	M	Direct
Common Stock	Disposition	2017-09-27	7,885	$39.50	26,046	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2017-09-27	7,885	$0.00	7,885	$22.03

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0		2018-03-14	No	4	M	Direct

Footnotes

The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Havey.
Consists of an option granted under the company's stock incentive plan as amended and restated.
The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant.